Come & Meet us on the Sebia booth #121

Location: ICM Internationales Congress Center, Munich

 

Sebia Workshop EduW22

WHAT’S NEW IN MINIMAL RESIDUAL DISEASE TESTING FOR MULTIPLE MYELOMA?

Date: Tuesday, November 30th

From 15:30 to 16:30

Room: 13b

 

Moderator:

  • Dr. Martijn VAN DUIJN, PhD
    Erasmus Medical Center – Rotterdam, THE NETHERLANDS

 

Speakers:

  • Dr. Thomas DEJOIE, PharmD
    Biochemical Laboratory, University Hospital of Nantes – Nantes, FRANCE
    Overview of MRD testing in Myeloma and current needs
  • Dr. Joannes (Hans) F.M. JACOBS, PhD, MD
    Radbound University Medical Center – Nijmegen, THE NETHERLANDS
    Mass spectrometry as a tool for MRD detection in the blood of Myeloma patients